Global Freight Procurement & RFQ Lead
Azenta
Global Freight Procurement & RFQ Lead
Azenta
Automated cold-chain sample management and multiomics
Duration 6 months
Based in Wotton, Surrey
The Global Freight Procurement & RFQ Lead will be responsible for completing a full diagnostic review of Azenta’s global freight spend, carrier base, freight forwarding arrangements, courier/parcel activity, commercial terms and service performance.
This role is expected to challenge current freight purchasing and transportation arrangements, identify cost and service improvement opportunities, and take the business out to market through a robust RFQ/RFP process.
Working closely with Operations, Procurement, Finance, Sales, Customer Service and regional stakeholders, the role will evaluate existing and potential freight providers across relevant transport modes and geographies. The output will be a clear recommendation pack for leadership, outlining provider options, commercial benefits, service-level improvements, implementation considerations, and the recommended global freight strategy.
Scope clarification: This contract is focused on freight spend and transportation provider sourcing only. It does not include a review of current contracted 3PL warehousing, fulfilment or site operating arrangements, which will be managed as a separate review due to existing contractual commitments.
Azenta is an Equal Opportunity Employer. This company considers candidates regardless of race, color, age, religion, gender, sexual orientation, gender identity, national origin, disability or veteran status.
Azenta provides life sciences solutions focused on end-to-end sample management and genomic services. It combines automated ultra-cold storage, cryogenics, consumables, instruments, and repository services with genomic services like sequencing and gene synthesis through its GENEWIZ brand. The company offers an integrated stack of hardware, consumables, software (LIMS like Limfinity and Freezer Pro), and services to collect, store, and analyze biological samples across their lifecycle. Its end-to-end portfolio and recurring revenue, supported by acquisitions, differentiate it from competitors and aim to speed up drug development, clinical research, and advanced cell therapies by preserving sample integrity from collection to analysis.
Explore more opportunities at Azenta